Investigating the long-term effects of COVID-19 in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study enrolls pediatric patients aged 6-18 who have been diagnosed with COVID-19 to assess the long-term effects of the virus, specifically focusing on neurological and psychiatric outcomes. Participants will undergo brain MRI and neuropsychiatric evaluations 4-6 months after their COVID-19 diagnosis, with a follow-up evaluation one year later for longitudinal analysis. Healthy age- and gender-matched participants will also be included for comparative purposes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 6-18 years old
* Has been diagnosed COVID-19 before

Exclusion Criteria:

* History of neuropsychiatric disorders
* Have some device not allowed for MRI

Where it's running

• National Taiwan University Children Hospital Pediatric Neurology Department
  Taipei, Taiwan Recruiting

Study contacts

• Principal investigator: Wang-Tso Lee, PHD — National Taiwan University Children Hospital Pediatric neurology department
• Study coordinator: Wang-Tso Lee, PHD
• Email: leeped@hotmail.com
• Phone: (886)2-23123456

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID

  This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.

  Recruiting Oxford Brookes University · Oxford, Oxon · NCT07874217

• Fatigue Investigation Using Digital Outcomes

  This study tests whether digital monitoring with a smartphone app and wearables can track fatigue in people with MS or long COVID, compared with healthy volunteers.

  Recruiting at 6 sites University of Zurich · Basel, Basel and 5 other locations · NCT07783074

• Biomarker study to understand Long COVID using VIPER

  This study tests biomarkers in people with Long COVID and those who recovered from COVID-19 to see how they can diagnose and track the condition over time.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07770022

• PERCEIVE-Outreach: A scalable care model to help people with Long COVID manage heart and lung symptoms

  This study tests a remote care model to see if a personalized, telehealth-based exercise program helps adults with Long COVID feel better and move more.

  Recruiting University of Tasmania · Hobart, Tasmania and 1 other locations · NCT07661862

• Testing PNMR plus standard care for long COVID

  We’re trying PNMR along with standard care to see if it helps people with long COVID better than standard care alone.

  Recruiting at 4 sites Phase 2 ParagonClinicals Inc. · Brampton, Ontario and 3 other locations · NCT07627815

• Combination therapy for Long COVID symptoms using valacyclovir, celecoxib, and Paxlovid

  This study tests whether a three-drug combination can reduce Long COVID symptoms in adults compared with a placebo.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07597902

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.